Oxford BioDynamics seeks £500,000 through retail share offering By Investing.com

LONDON – Oxford BioDynamics PLC (LON:), a clinical diagnostics company specializing in precision medicine, has announced a retail bid to raise up to £500,000 through a new share issue. This offer is exclusive to current eligible shareholders in the United States Kingdom (Trading:) It is conducted via the Winterflood Retail Access (WRAP) platform.

The offering includes up to 100,000,000 new ordinary shares at an issue price of 0.5 pence per share. The issue price represents a 44% discount to the average market closing price of 0.9 pence per ordinary share on Sunday. The funds raised will be used similarly to the proceeds of a concurrent placement and subscriptions aiming to raise at least £6 million.

The individuals offer is part of a wider fundraising strategy by the company, which is contingent on shareholder approval at a general meeting scheduled for 31 January 2025 and the subsequent acceptance of the new shares for trading on the company’s AIM market. London Stock Exchange (line:). Trading is expected to begin on February 4, 2025.

Oxford BioDynamics is reaching out to its UK retail shareholder base, providing an opportunity to participate in the company’s growth. The minimum entry per investor has been set at £250, with the offer closing at 4.30pm on Thursday this week. Shareholders interested in participating can contact their brokers or wealth managers.

The new common shares issued will be fully paid up and pari passu with the outstanding common shares, including the right to receive dividends and other distributions declared after the date of issuance.

Investors are reminded that investing in the company involves risk and that capital is at stake. The value of investments can fluctuate, which may result in investors receiving less than their original investment.

This announcement is based on a press release and does not constitute an offer or solicitation in jurisdictions where such actions would violate applicable laws. The Offer is not being made in the United States, Australia, Canada, New Zealand, Japan, South Africa, any member state of the European Economic Area or any jurisdiction where it would be unlawful. The retail offering shares will not be registered under U.S. securities law and will not be offered in the United States.

The information provided in this article is for basic purposes and does not claim to be complete or complete. It is based on a press release and should be read in conjunction with the company’s full announcement to gain a comprehensive understanding of the terms and conditions of the offer.

This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.